Genetic loci for Epstein-Barr virus nuclear antigen-1 are associated with risk of multiple sclerosis

Multiple Sclerosis

Volumn 22, Issue 13, 2016, Pages 1655-1664

  Zhou, Yuan ^a   Zhu, Gu ^b   Charlesworth, Jac C ^a   Simpson, Steve ^a   Rubicz, Rohina ^c   Göring, Harald H H ^d   Patsopoulos, Nikolaos A ^e,f,g   Laverty, Caroline ^h   Wu, Feitong ^a   Henders, Anjali ^b   Ellis, Jonathan J ^b   Van Der Mei, Ingrid ^a   Montgomery, Grant W ^b   Blangero, John ^d   Curran, Joanne E ^d   Johnson, Matthew P ^d   Martin, Nicholas G ^b   Nyholt, Dale R ^b,i   Taylor, Bruce V ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c USA   (United States)

^d University of Texas Rio Grande Valley School of Medicine   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^h MONASH UNIVERSITY   (Australia)

ⁱ QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

EBNA 1; Epstein Barr virus; GWAS; multiple sclerosis; non HLA; polygenic risk

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; HLA ANTIGEN; IMMUNOGLOBULIN G; EBV-ENCODED NUCLEAR ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EBNA1 GENE; GENE EXPRESSION; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MEXICAN AMERICAN; MULTIPLE SCLEROSIS; SINGLE NUCLEOTIDE POLYMORPHISM; GENOME-WIDE ASSOCIATION STUDY; META ANALYSIS; RISK; TWINS;

EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MULTIPLE SCLEROSIS; RISK;

EID: 84994593546     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458515626598     Document Type: Article

References (39)

1. Lucas RM, Hughes AM, Lay ML, et al. Epstein-Barr virus and multiple sclerosis. J Neurol Neurosurg Psychiatry 2011; 82: 1142-1148.
2. Young LS, Rickinson AB,. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004; 4: 757-768.
3. Pender MP,. CD8+ T-cell deficiency, Epstein-Barr virus infection, vitamin D deficiency, and steps to autoimmunity: A unifying hypothesis. Autoimmun Dis 2012; 2012: 189096.
4. Simpson S Jr, Blizzard L, Otahal P, et al. Latitude is significantly associated with the prevalence of multiple sclerosis: A meta-analysis. J Neurol Neurosurg Psychiatry 2011; 82: 1132-1141.
5. Pakpoor J, Disanto G, Gerber JE, et al. The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: A meta-analysis. Mult Scler 2013; 19: 162-166.
6. Munger KL, Levin LI, O'Reilly EJ, et al. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: A prospective study among United States military personnel. Mult Scler 2011; 17: 1185-1193.
7. Strautins K, Tschochner M, James I, et al. Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk. Mult Scler 2014; 20: 286-294.
8. Lunemann JD, Jelcic I, Roberts S, et al. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J Exp Med 2008; 205: 1763-1773.
9. Cepok S, Zhou D, Srivastava R, et al. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 2005; 115: 1352-1360.
10. Lunemann JD, Tintore M, Messmer B, et al. Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann Neurol 2010; 67: 159-169.
11. Farrell RA, Antony D, Wall GR, et al. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology 2009; 73: 32-38.
12. Levin LI, Munger KL, Rubertone MV, et al. Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005; 293: 2496-2500.
13. Lucas RM, Ponsonby AL, Dear K, et al. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination. Neurology 2011; 77: 371-379.
14. Levin LI, Munger KL, O'Reilly EJ, et al. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol 2010; 67: 824-830.
15. Ascherio A, Munger KL, Lunemann JD,. The initiation and prevention of multiple sclerosis. Nat Rev Neurol 2012; 8: 602-612.
16. Rubicz R, Yolken R, Drigalenko E, et al. A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1). PLoS Genet 2013; 9: e1003147.
17. Zhu G, Montgomery GW, James MR, et al. A genome-wide scan for naevus count: Linkage to CDKN2A and to other chromosome regions. Eur J Hum Genet 2007; 15: 94-102.
18. Wright MJ, Martin NG,. Brisbane Adolescent Twin Study: Outline of study methods and research projects. Aust J Psychol 2004; 56: 65-78.
19. Ferreira MA, Mangino M, Brumme CJ, et al. Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control. Am J Hum Genet 2010; 86: 88-92.
20. Abecasis GR, Cherny SS, Cookson WO, et al. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002; 30: 97-101.
21. Almasy L, Blangero J,. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998; 62: 1198-1211.
22. Liu JZ, Tozzi F, Waterworth DM, et al. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet 2010; 42: 436-440.
23. International Multiple Sclerosis Genetics Consortium; Beecham AH, Patsopoulos NA, Xifara DK, et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013; 45: 1353-1360.
24. Lee D, Bigdeli TB, Riley BP, et al. DIST: Direct imputation of summary statistics for unmeasured SNPs. Bioinformatics 2013; 29: 2925-2927.
25. Patsopoulos NA, Bayer Pharma MS Genetics Working Group, Steering Committees of Studies Evaluating IFNβ-1b and a CCR1-Antagonist et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 2011; 70: 897-912.
26. Nyholt DR,. SECA: SNP effect concordance analysis using genome-wide association summary results. Bioinformatics 2014; 30: 2086-2088.
27. International Schizophrenia Consortium; Purcell SM, Wray NR, Stone JL, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748-752.
28. Lin R, Charlesworth J, Stankovich J, et al. Identity-by-descent mapping to detect rare variants conferring susceptibility to multiple sclerosis. PLoS ONE 2013; 8: e56379.
29. Willer CJ, Li Y, Abecasis GR,. METAL: Fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010; 26: 2190-2191.
30. Emily M, Mailund T, Hein J, et al. Using biological networks to search for interacting loci in genome-wide association studies. Eur J Hum Genet 2009; 17: 1231-1240.
31. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010; 7: 248-249.
32. Kumar P, Henikoff S, Ng PC,. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009; 4: 1073-1081.
33. Reva B, Antipin Y, Sander C,. Predicting the functional impact of protein mutations: Application to cancer genomics. Nucleic Acids Res 2011; 39: e118.
34. Lim YS, Tang BL,. The Evi5 family in cellular physiology and pathology. FEBS Lett 2013; 587: 1703-1710.
35. Hoppenbrouwers IA, Aulchenko YS, Ebers GC, et al. EVI5 is a risk gene for multiple sclerosis. Genes Immun 2008; 9: 334-337.
36. Australia New Zealand Multiple Sclerosis Genetics Consortium. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009; 41: 824-828.
37. Mowry EM, Carey RF, Blasco MR, et al. Multiple sclerosis susceptibility genes: Associations with relapse severity and recovery. PLoS ONE 2013; 8: e75416.
38. Van Aalderen MC, Remmerswaal EB, Verstegen NJ, et al. Infection history determines the differentiation state of human CD8+ T cells. J Virol 2015; 89: 5110-5123.
39. Parnell GP, Gatt PN, Krupa M, et al. The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease. Clin Immunol 2014; 151: 16-24.